If you’re comparing addiction treatment programs in Shreveport, understanding what each facility accepts and what level of supervision it provides is a critical first step for those who are struggling with alcohol or substance use disorder.
A 2021 Louisiana law now requires all licensed residential SUD facilities that treat opioid use disorder to maintain onsite access to at least one FDA-approved opioid agonist treatment and one opioid antagonist treatment.
That means any residential detox program in Shreveport treating opioid dependence should be able to offer or immediately connect patients to medication-assisted treatment during their stay, reducing barriers to life-saving pharmacological support.
Drug and alcohol detox facilities in Shreveport operate under licensure from the Louisiana Department of Health’s Office of Behavioral Health (LDH-OBH), which sets standards for staffing, patient care and facility operations across all levels of SUD treatment, including medical detox, residential and outpatient programs.
To support the community, Caddo Parish received $3.6 million in opioid settlement funds as of October 2024, part of Louisiana’s roughly $600 million total allocation from multi-company settlements running through 2038. How that money is distributed locally matters for residents, as the settlement guidance prioritizes treatment access, harm reduction and criminal justice diversion.
For individuals without insurance coverage, the Council on Alcoholism and Drug Abuse of Northwest Louisiana (CADA) is a longstanding nonprofit in Shreveport offering residential treatment, outpatient programs and adolescent services. CADA accepts Medicaid and works with patients regardless of ability to pay, making it a key safety-net option for residents without private coverage.
